Jang Moon, MD Email Jang Moon
-
- Position
- ASSOCIATE PROFESSOR | Surgery
-
- Specialties
- Intestinal Transplantation
- Liver Surgery
- Surgery
- Liver Transplantation
-
- Languages
- English
- Korean
-
- Hospital Affiliation
- The Mount Sinai Hospital
-
- Phone
- RMTI - Liver and Intestinal Transplant Programs 212-659-9300212-659-9300
-
RMTI - Liver and Intestinal Transplant Programs
5 East 98th st.
12th Floor
New York, NY 10029
Phone: 212-659-9300212-659-9300
Dr. Jang Moon is a Fellow of the American College of Surgeons, specializing in Intestinal and Liver transplantation. He has expertise in the treatment of patients with various acute/chronic liver and bowel diseases including liver cirrhosis, ischemic bowel disease, short bowel syndrome, enterocutaneous fistula and intestinal pseudo-obstruction. Dr. Moon has various clinical research interests including improvement of clinical outcomes in liver and intestinal transplant, quality of life after transplant and transplant immunology.
RMTI Website: www.mountsinairmti.org
Clinical Focus
- Cirrhosis
- Enterocutanaeus Fistula
- Liver Transplant
- Short Bowel Syndrome
Education
MD, Yonsei University College of Medicine
Residency, Surgery
Yonsei University College of Medicine
Fellowship, Transplant
Yonsei University College of Medicine
Fellowship, Transplant
Jackson Memorial Hospital
Languages
English, Korean
Moon JI, Tzakis AG. Intestinal and multivisceral transplantation. Yonsei medical journal 2004 Dec; 45(6).
Moon JI, Selvaggi G, Nishida S, Levi DM, Kato T, Ruiz P, Bejarano P, Madariaga JR, Tzakis AG. Intestinal transplantation for the treatment of neoplastic disease. Journal of surgical oncology 2005 Dec; 92(4).
Moon J, Iyer K. Intestinal rehabilitation and transplantation for intestinal failure. The Mount Sinai journal of medicine, New York; 79(2).
Yu HC, Tuteja S, Moon JI, Kleiner GI, Conanan L, Gaynor JJ, Kato T, Levi DM, Nishida S, Selvaggi G, Gandia C, Weppler D, Esquenazi V, Ruiz P, Miller J, Tzakis AG. Utilization of dried blood spot citrulline level as a noninvasive method for monitoring graft function following intestinal transplantation. Transplantation 2005 Dec; 80(12).
Selvaggi G, Gaynor JJ, Moon J, Kato T, Thompson J, Nishida S, Levi D, Ruiz P, Cantwell P, Tzakis AG. Analysis of acute cellular rejection episodes in recipients of primary intestinal transplantation: a single center, 11-year experience. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007 May; 7(5).
Moon JI, Barbeito R, Faradji RN, Gaynor JJ, Tzakis AG. Negative impact of new-onset diabetes mellitus on patient and graft survival after liver transplantation: Long-term follow up. Transplantation 2006 Dec; 82(12).
Gaynor JJ, Moon JI, Kato T, Nishida S, Selvaggi G, Levi DM, Island ER, Pyrsopoulos N, Weppler D, Ganz S, Ruiz P, Tzakis AG. A cause-specific hazard rate analysis of prognostic factors among 877 adults who received primary orthotopic liver transplantation. Transplantation 2007 Jul; 84(2).
Moon J, Island E, Weppler D, Kato T, Tekin A, Selvaggi G, Nakamura N, Ruiz P, Nishida S, Levi D, Martin P, Schiff E, Tzakis AG. Liver transplantation at the Miami Transplant Institute: a 14-year single-center experience. Clinical transplants 2007;.
Kim DY, Moon J, Island ER, Tekin A, Ganz S, Levi D, Selvaggi G, Nishida S, Tzakis AG. Liver transplantation using elderly donors: a risk factor analysis. Clinical transplantation; 25(2).
Moon JI, Nishida S, Butt F, Schwartz CB, Ganz S, Levi DM, Burke GW, Tzakis AG. Multi-organ procurement and successful multi-center allocation using rapid en bloc technique from a controlled non-heart-beating donor. Transplantation 2004 May; 77(9).
Moon JI, Ciancio G, Burke GW. Arterial reconstruction with donor iliac vessels during pancreas transplantation: an intraoperative approach to arterial injury or inadequate flow. Clinical transplantation 2005 Apr; 19(2).
Mosna LC, Moon J, Hernandez F, Hodgkinson P, Fan J, Selvaggi G, Tekin A, Nishida S, Levi D, Tzakis AG. Use of the subcutaneous route and polytetrafluoroethylene grafts for arterial revascularization in liver transplantation. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2012 Apr; 18(4).
Moon JI, Kim YS, Kim MS, Kim EH, Kim HJ, Kim SI, Park K. Effect of cyclosporine, mycophenolic acid, and rapamycin on the proliferation of rat aortic vascular smooth muscle cells: in vitro study. Transplantation proceedings 2000 Nov; 32(7).
Yu HC, You H, Lee H, Jin ZW, Moon JI, Cho BH. Estimation of standard liver volume for liver transplantation in the Korean population. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2004 Jun; 10(6).
Yu HC, Moon JI, Jin ZW, Lee DY, Kim CY, Song CH, Cho BH. Effect of radiofrequency ablation of the liver on cell-mediated immunity in rats. World journal of surgery 2005 Jun; 29(6).
Jin GY, Yu HC, Lim HS, Moon JI, Lee JH, Chung JW, Cho BH. Anatomical variations of the origin of the segment 4 hepatic artery and their clinical implications. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2008 Aug; 14(8).
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Moon did not report having any of the following types of financial relationships with industry during 2017 and/or 2018: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website.
Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.